The adapter protein Slp65 and Bruton's tyrosine kinase (Btk) are key components of the precursor-B (pre-B) cell receptor (pre-BCR) signaling pathway. Slp65-deficient mice spontaneously develop pre-B-cell leukemia, expressing high levels of the pre-BCR on their cell surface. As leukemic Slp65-deficient pre-B cells express the recombination activating genes (Rag)1 and Rag2, and manifest ongoing immunoglobulin (Ig) light-chain rearrangement, it has been hypothesized that deregulated recombinase activity contributes to malignant transformation. In this report, we investigated whether Rag-induced DNA damage is involved in oncogenic transformation of Slp65-deficient B cells. We employed Btk/Slp65 doubledeficient mice carrying an autoreactive 3-83ld BCR transgene. When developing B cells in their bone marrow express this BCR, the V(D)J recombination machinery will be activated, allowing for secondary Ig light-chain gene rearrangements to occur. This phenomenon, called receptor editing, will rescue autoreactive B cells from apoptosis. We observed that 3-83ld transgenic Btk/Slp65 double-deficient mice developed B-cell leukemias expressing both the 3-83ld BCR and the pre-BCR components k5/VpreB. Importantly, such leukemias were found at similar frequencies in mice concomitantly deficient for Rag1 or the non-homologous end-joining factor DNA-PKcs. We therefore conclude that malignant transformation of Btk/Slp65 double-deficient pre-B cells is independent of deregulated V(D)J recombination activity.
Introduction
Diversity of immunoglobulin (Ig) and T-cell receptor specificities is generated through DNA-gene rearrangement initiated by lymphocyte-specific proteins encoded by the recombination activating genes Rag1 and Rag2 (for reviews, see Jung et al., 1 Soulas-Sprauel et al. 2 and Hardy et al.
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). The Rag complex recognizes and cleaves specific DNA elements, called recombination recognition sequences (RSS), which flank rearranging V, D and J gene segments. The arising double-strand DNA breaks are subsequently resolved by the non-homologous end-joining (NHEJ) pathway. Because of this unique feature of lymphoid cells to somatically rearrange antigen receptor genes, these cells are frequent targets for chromosomal translocations and oncogene activation resulting from recombinase-targeting mistakes or incorrect repair of the V(D)J recombination intermediates. 4, 5 It was demonstrated in the mouse that chromosomal reinsertion of broken RSS can target cryptic RSS-like elements through a V(D)J recombination-like mechanism. 6 Moreover, cryptic RSS sequences immediately internal to the deletion breakpoints in the IKZF1 locus, encoding the transcription factor IKAROS, have been identified in human BCR-ABL1 þ acute lymphoblastic leukemia (ALL). 7 Cryptic RSS are estimated to have a density of 1 per 600 bp in the genome and have been identified in other loci involved in ALL, including PAX5 and CDKN2A/B in human and c-Myc and Lmo2 in the mouse. 8, 9 In addition, Rag proteins have the ability to rearrange DNA sequences that do not resemble RSS, as reported in follicular lymphoma. 10 Taken together, these findings suggest that gene deletion or translocation arising from aberrant Rag activity contributes to leukemogenesis in human and mouse ALL.
Productive Ig heavy (IgH) chain V(D)J recombination in pro-B cells results in deposition of IgH m chain on the cell surface together with the non-rearranging surrogate light chain (SLC) components l5 and VpreB. [11] [12] [13] [14] Signaling from this precursor-Bcell receptor (pre-BCR) monitors expression of a functional IgH chain and triggers clonal expansion, leading to differentiation into large cycling pre-B cells as pre-B cells acquire the capacity to respond to low concentrations of the proliferation factor interleukin (IL)-7. [11] [12] [13] 15 In large cycling pre-B cells, Rag proteins are transiently downregulated to terminate further IgH chain rearrangement, thus ensuring that only one functional IgH chain is assembled, a phenomenon termed allelic exclusion. Moreover, as ongoing recombinase activity during mitosis will interfere with faithful transmission of the genome to daughter cells, Rag2 proteins are degraded during cell division, thus linking V(D)J recombination to the cell cycle. 16 Developmental progression from large cycling into small resting pre-B cells is associated with reactivation of the V(D)J recombination machinery for Ig light (IgL) chain gene rearrangement and with cell-surface marker changes. [11] [12] [13] [14] The adapter protein Slp65 (also known as Blnk or Bash) and Bruton's tyrosine kinase (Btk) are key components in the signaling pathway downstream of the pre-BCR and the BCR. Slp65, when phosphorylated by the Syk kinase, provides docking sites for various molecules, including Btk and phospholipase C (PLCg). Btk then phosphorylates PLCg, which leads to its full activation and the generation of second messengers. [11] [12] [13] [14] In human, mutations in SLP65 or BTK result in defective pre-B-cell proliferation and an almost complete arrest of early B-cell development, associated with the immunodeficiency disorder agammaglobulinemia. 11, 17 In mice, deficiency for Slp65 or Btk leads to a partial arrest of early B-cell development. 11 Importantly, 5-10% of Slp65-deficient mice develop pre-B-cell leukemia expressing high levels of pre-BCR on the cell surface. 18, 19 Btk cooperates with Slp65 as a tumor suppressor, independently of its kinase activity. 20, 21 In a substantial fraction of human pre-B ALL, including cases expressing the oncogenic BCR-ABL1 tyrosine kinase fusion protein, SLP65 expression is defective because of aberrant splicing. 22, 23 But it has also been reported that SLP65 deficiency may be an infrequent event in human pre-B-lineage ALL, 7, 24 and thus the importance of loss of SLP65 expression as one of the primary causes of pre-B ALL in human remains unclear.
Slp65 function is essential for proper progression of large cycling into small resting pre-B cells. Slp65 collaborates with Btk to downregulate SLC and IL-7 receptor (IL-7R) expression. 18, 20 It also directly inhibits the IL-7R signaling component Jak3, 25 thereby terminating the proliferative response to IL-7 and reducing expression of bcl-2 family anti-apoptotic proteins and c-Myc. Finally it has been shown that Slp65 induces cell cycle arrest through upregulation of Ikaros, which controls gene expression through its association with chromatin remodeling complexes. 26 The mechanism by which Slp65 exerts its tumor suppression function in mice has not been completely elucidated to date, but striking parallels exist with pre-B-cell tumors initiated by deregulated expression of the c-Myc oncogene. Malignant transformation of both Slp65-deficient and Em-myc transgenic pre-B cells (i) involves disruption of the p19
Arf -Mdm2-p53 tumor suppressor pathway, 27, 28 (ii) is reduced by expression of a pre-rearranged IgH chain transgene in early B-cell differentiation, 28, 29 and is (iii) independent of activation-induced deaminase. 28, 30 Moreover, loss of Btk or PLC-g2 synergizes with deregulation of c-Myc during lymphoma formation in Em-myc mice. 31, 32 Several lines of evidence have indicated a role for unregulated Rag activity in Slp65-deficient pre-B-cell leukemia. First, Rag proteins are expressed in strongly proliferating Slp65-deficient pre-B cells. 18, 19 Second, Slp65-deficient pre-B-cell leukemias mostly co-express IgH chain, SLC and IgL chain. 20 Third, in human pre-B-cell leukemia SLP65 deficiency correlates with RAG expression and ongoing V H gene rearrangement activity. 33 Importantly, it has been recently demonstrated that Ragmediated DNA breaks are not essential for malignant transformation in Em-Myc Tg mice. 30 We have previously demonstrated the effects of transgenic IgH chain expression and p53-deficiency on oncogenic transformation of Slp65-deficient pre-B cells. 28 However, genetic experiments addressing the requirement of Rag-mediated V(D)J recombination events in leukemia formation have not been performed. Therefore, we investigated whether oncogenic transformation of Slp65-deficient pre-B cells could occur on a Rag1-deficient background. We found that leukemia in Btk/Slp65 double-deficient mice arises independently of V(D)J recombination activity or illegitimate repair by NHEJ.
Materials and methods

Mice and genotyping
Mice deficient for Btk, 34 Rag1 35 and DNA-PKcs (Jackson Laboratories, Bar Harbor, ME, USA) were on the C57BL/6 background. 3-83md mice 36 were on a non-deleting B10.D2 background. Slp65-deficient mice 37 were on the Balb/c background. The different composite genotypes were on a mixed background and in single experiments littermates were compared. For mouse genotyping genomic DNA was analyzed by PCR, as previously described. 20, 28 Animals in tumor panels were killed after indication of tumor formation, or after a maximum period of 40 weeks of age. Mice were bred and maintained in the Erasmus MC animal care facility under pathogen-free conditions. Experimental procedures were reviewed and approved by the Erasmus MC committee of animal experiments.
Southern blotting
Genomic DNA (10 mg) was digested with HindIII (New England Biolabs, Beverly, MS, USA) and processed by southern blotting using nylon membrane (Nytran SPC, GE Healthcare, Pittsburgh, PA, USA) and standard procedures. Fragments were visualized by phosphorImager (Storm, Molecular Dynamics, Sunnyvale, CA, USA) and analyzed with ImageQuant (Molecular Dynamics). Probe specific for J k , a 1.6 kb EcoRI fragment, was labeled by random priming.
Flow cytometry and in vivo
Preparations of single-cell suspensions, flow cytometry procedures and monoclonal antibodies have been described previously. 20, 34, 38 The anti-3-83md hybridoma 54-1 (Nemazee and Burki
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) was kindly provided by D Nemazee (The Scripps Research Institute, La Jolla, CA, USA). Bone marrow (BM) cell suspensions were depleted of erythrocytes by standard ammonium chloride lysis and IL-7 driven cultures were performed as described previously. 38 For intracellular staining of cytoplasmic proteins, cells were first stained for cell surface markers and subsequently fixed in 2% paraformaldehyde and permeabilized using 0.5% saponin. Events (1-5 Â 10 5 ) were scored using a BD FACSCalibur or LSRII flow cytometer (BD Biosciences, San Diego, CA, USA) and analyzed using FlowJo software (Tree Star, Ashland, OR, USA).
BrdU (BD Biosciences) was dissolved in PBS at 2 mg/ml. Mice were injected i.p. with 200 ml. Total BM cell suspensions were analyzed by flow cytometry for BrdU incorporation, using the BrdU flow kit (BD Biosciences) in conjunction with cell-surface marker expression, as previously described. 38 
Results
Ongoing IgL chain gene recombination in Slp65-deficient pre-B-cell leukemias
By flow cytometry we found co-expression of IgL chain and SLC, as previously reported, 20 in most Slp65-deficient or Btk/Slp65 double-deficient pre-B-cell leukemias. The proportions of Ig k or l L chain expressing leukemic cells were 16±2% (n ¼ 30) and 1.5 ± 0.3% (n ¼ 22), respectively. Normally, large cycling pre-B cells contain low levels of Rag transcripts, 3 but when we analyzed the pre-B-cell leukemias by quantitative RT-PCR we found substantial expression ( Figure 1a ). Transcription of Rag1 and Rag2 was B2-3-fold higher in Btk/Slp65 double-deficient pre-B leukemias than in Slp65-deficient leukemias, most likely reflecting the more severe phenotype of Btk/Slp65 doublemutant mice, as compared with Slp-65 single-mutant mice. 20, 40 Consistent with the expression of Ig k L chain protein, various clonal V k -J k rearrangement patterns were detected next to the germline J k restriction fragment in southern blotting analyses, using a J k -specific probe (Figures 1b and c) . In most of the leukemia samples analyzed, we observed multiple J k restriction fragments, indicating oligoclonality. The IgL chain recombination is generally initiated in small resting pre-B cells that have terminated SLC expression. 1, 11 Therefore, the finding that Slp65-deficient or Btk/Slp65 double-deficient pre-B-cell leukemias contained oligoclonal Ig k þ B cell fractions co-expressing SLC suggested ongoing IgL chain gene rearrangement after leukemic transformation of pre-B cells.
Btk/Slp65 double-deficient pro-B cells are not susceptible to malignant transformation
To investigate the involvement of V(D)J recombination in malignant transformation, we first crossed Btk/Slp65 double-deficient mice with mice deficient for Rag1. As Btk/ Slp65/Rag triple-deficient mice cannot express a functional IgH m chain, they manifested an arrest of B-cell development at the pro-B-cell stage, as was found for the Rag1 single-deficient mice. 35 Btk/Slp65/Rag triple-deficient mice did not develop leukemia (Table 1) , in agreement with the previously reported finding that proliferation is mediated by high pre-BCR expression and not due to the absence of Slp65 per se.
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Defective NHEJ does not enhance malignant transformation of Btk/Slp65 double-deficient pro-B or pre-B cells Next, we analyzed whether defective NHEJ, which is associated with increased Rag-mediated double-strand DNA breaks that remain unresolved in B and T lymphocytes, contributed to leukemia formation. We crossed Btk/Slp65 double-deficient mice with mice that harbor a defect in the NHEJ pathway component DNA-PKcs, encoded by the Prkdc gene. 41 In contrast to Rag1-deficient mice, DNA-PKcs-deficient mice have an incomplete block at the pro-B-cell stage and very low but detectable numbers of pre-B cells are present in the BM. [42] [43] [44] When compared with these DNA-PKcs-deficient mice, the numbers of intracellular IgH m chain-positive pre-B cells in Btk/Slp65/DNA-PKcs tripledeficient mice were slightly increased, probably because of enhanced proliferative expansion of pre-B cells (Figure 2a) . Accordingly, we found that the membrane IgL chain-negative cell fraction contained more surface SLC þ pre-B cells in Btk/Slp65/DNA-PKcs triple-than in DNA-PKcs single-deficient mice ( Figure 1b) . Next, we investigated if the increased proliferation capacity of Btk/Slp65-deficient pre-B cells 20 could correct the low generation of pre-B cells in DNA-PKcs-mutant mice. When mice were pulsed with a single dose of the thymidine analog BrdU, which is selectively incorporated into the DNA of large pre-B cells, 38 the absolute numbers of BrdU þ large pre-B cells in the BM of DNA-PKcs-deficient mice were severely reduced, when compared with wild-type mice (Figure 2c ). The absolute numbers of BrdU þ large pre-B cells in Btk/Slp65/DNA-PKcs triple-mutant mice were variable and only slightly increased, when compared with DNA-PKcs-deficient mice. Within the fractions of pre-B cells the proportions of BrdU þ cells were comparable between wild type and mice deficient for DNA-PKcs, Btk/Slp65 or Btk/Slp65/DNA-PKcs (Figure 2d) . Therefore, proliferation of Btk/Slp65/DNA-PKcs triple-mutant pre-B cells was not substantially increased in vivo, when compared with Btk/Slp65 double-mutant mice, even though the BM in these mice may contain more empty niches or available space because of the block in B-cell development.
Whereas in the Btk/Slp65 double-deficient control group 15 out of 36 mice developed pre-B-cell leukemia (Table 1) , none of the 22 Btk/Slp65/DNA-PKcs triple-mutant mice that were followed for 6 months showed signs of leukemia formation, even when we examined BM and spleen of these mice in detail by flow cytometry (data not shown). We conclude that pro-B cells and pre-B cells generated in Btk/Slp65/DNA-PKcs triple-mutant mice are not particularly susceptible to malignant transformation, in spite of defective NHEJ.
Autoreactive receptor editing Btk/Slp65 double-deficient B cells express high levels of pre-BCR
The complete absence or severe reduction of the size of the pre-B-cell compartment in Btk/Slp65 mutant mice with additional mutations in the Rag1 or Prkdc genes, precluded the analysis of leukemia development in these mice. However, when the developmental block at the pro-B-cell stage was rescued by transgenic expression of the pre-rearranged IgH chain transgene VH81X, tumor development was also prevented Abbreviation: n.a., not applicable.
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in Btk/Slp65 mutant mice. 28 This could be explained by an acceleration of the passage of B-cell precursors through the pro-B-cell stage, which may reduce the size of the cell population most susceptible to transformation.
Therefore, we employed Btk/Slp65 deficient mice carrying the 3-83md transgene, which consists of pre-rearranged Ig m and d H chain genes and an Ig k L chain gene encoding an antibody that specifically recognizes major histocompatibility complex (MHC) class I H-2K b,d . 36 In developing B cells in the BM, on a centrally deleting H-2K b C57BL/6 background, the expressed BCR is autoreactive and therefore the V(D)J recombination machinery remains active. As a result, secondary Ig L chain gene rearrangements occur and hence autoreactive B cells can be rescued from apoptosis, a phenomenon called receptor editing. [45] [46] [47] By contrast, the 3-83md Tg on a non-H2-K b,d
background reflects an innocuous BCR and the arising B cells are not autoreactive and will not be deleted or edited.
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On a non-deleting background, splenic B cells from 3-83md transgenic mice expressed the 3-83md BCR, as analyzed by staining with the anti-idiotypic antibody 54-1 ( Figure 3a) . As previously described splenic B cell numbers were very low in Btk/Slp65 double-deficient mice, 20 irrespective of the presence of the 3-83md transgene (Figure 3a) . When the 3-83md Tg was expressed on a wild type deleting background, those B cells present had lost 54-1 reactivity and increased usage of Ig l L chain, indicating that they had edited the 3-83md BCR. On a deleting background, 3-83md transgenic Btk/Slp65 doubledeficient mice had only very few splenic B cells, but those B cells present were 54-1 low and had detectable Ig l usage (Figure 3a) , demonstrating that receptor editing is operational in Btk/Slp65 double-deficient mice.
In the BM, the presence of the 3-83md transgene on a deleting background resulted in BCR downregulation, as evidenced by low signals for surface m H chain and 54-1 (Figure 3b ). 
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These B cells still expressed high levels of m H chain in their cytoplasm, but SLC expression was limited precluding abundant surface expression of the pre-BCR. Also 3-83md transgenic Btk/Slp65 double-deficient B cells on a deleting background showed downregulation of m H chain expression, albeit more modest, and had reduced staining with 54-1. As these B cells expressed high levels of SLC, we conclude that these 3-83md transgenic Btk/Slp65 double-deficient B cells expressed the 3-83md H chain together with SLC as a pre-BCR (Figure 3b ). Taken together, these findings show that on a centrally deleting background autoreactive 3-83md transgenic Btk/Slp65 double-deficient B cells undergo receptor editing, whereby the expression of pre-BCR is significantly increased, when compared with wild type 3-83md transgenic mice.
Leukemia in Btk/Slp65 double-deficient mice arises independently of V(D)J recombination activity
As editing 3-83md transgenic Btk/Slp65 double-deficient B cells expressed high levels of SLC and IL-7R, it was conceivable that these mice were also susceptible to leukemia formation. Indeed when we followed panels of 3-83md transgenic Btk/Slp65 double-deficient mice for 40 weeks, about 10% developed leukemia. Therefore, this model was suitable to investigate the involvement of V(D)J recombination in malignant transformation of Slp65-deficient pre-B cells. First, we crossed the mice with mice deficient for Rag1. When we followed panels of 3-83md transgenic Btk/Slp65 double-deficient mice that were either Rag1 þ /À or Rag1 À/À , we found that tumor frequencies were similar: 2/23 and 2/20, respectively ( Table 2) . Irrespective of their Rag1 genotype, all these leukemias were positive for the anti-idiotypic antibody 54-1 (Figure 4) . They all expressed SLC and IL-7R and showed variable expression of the differentiation markers CD2 and CD43 (Figure 4) . In this respect, these leukemias were not different from those found in Slp65 single or Btk/Slp65 double-mutant mice. 20 From these findings, we conclude that leukemias in Btk/Slp65 double-deficient mice can arise in the absence of an intact V(D)J recombination machinery.
Finally, we wanted to test whether an increase of unresolved V(D)J recombinase-mediated double-strand DNA breaks would affect leukemia incidence. To this end, we followed panels of 3-83md transgenic Btk/Slp65 double-deficient mice that were either Prkdc þ /À or Prkdc À/À for 40 weeks. Again, we did not find differences in leukemia onset or incidence (Table 2) .
Consequently, we conclude that defective NHEJ does not enhance B-cell leukemia development in Btk/Slp65 doubledeficient mice.
Discussion
It has been reported that strongly proliferating Slp65-deficient pre-B cells express Rag proteins in mice 18, 19 and that SLP65 deficiency in human pre-B-cell leukemia correlates with RAG expression and ongoing V H gene rearrangement activity. 33 Furthermore, reconstitution of SLP65 expression in human SLP65-deficient leukemia and lymphoma cells resulted in downregulation of RAG1/2 expression and V(D)J recombination events. 33 In agreement with these findings in human SLP65-deficient malignancies, we found that Slp65-deficient pre-B-cell leukemias in mice contained oligoclonal Ig k þ B cell fractions co-expressing IgH and SLC, suggesting ongoing IgL chain gene rearrangement after leukemic transformation of pre-B cells. Therefore, deregulated V(D)J recombinase activity, involving multiple double-strand DNA break events, in pre-B cells may well introduce genetic aberrations contributing to malignant transformation or progression of Slp65-deficient pre-B cells.
However, in this report we observed that Btk/Slp65 doubledeficient mice, in which the V(D)J recombination machinery is activated during receptor editing, develop leukemia at similar frequencies when they are concomitantly mutant for Rag1 or the NHEJ factor DNA-PKcs. We therefore conclude that malignant transformation of Btk/Slp65 double-deficient pre-B cells is independent of deregulated V(D)J recombination activity Table 2 Leukemia development in panels of 3-83md Tg Btk/Slp65 double-deficient mice or defective NHEJ. In this respect, Slp65-deficient pre-B-cell leukemia does not differ from leukemia in mice with enforced c-Myc expression. 30 It is of note that during normal B-cell development, expression of the proto-oncogene c-Myc is induced by the IL-7R pathway 48 and that recently it has been shown that Slp65-deficient leukemias acquire autonomous IL-7R signaling by autocrine IL-7 production. 25 As c-Myc is induced by IL-7R signaling, it is well possible that sustained IL-7R signaling results in elevated levels of c-Myc expression (constitutively or transiently), contributing to transformation of Slp65-deficient pre-B cells. Consistent with this hypothesis, we detected c-Myc expression in Slp65-deficient leukemias by RT-PCR. 28 Nevertheless, in contrast to Rag1 deficient c-Myc transgenic mice that may develop IgH m À pro-B-cell tumors, it has been shown that transformation of Slp65-deficient B-lineage cells is fully dependent on pre-BCR expression and thus on functional IgH chain recombination. 18 Our conclusion that ongoing V(D)J recombination activity is not involved in malignant transformation of Slp65-deficient pre-B cells is in agreement with our previous observation that Slp65-deficient pre-B-cell leukemias exhibited chromosomal instability but showed no evidence for Rag-mediated translocations by spectral karyotyping analysis. 28 Therefore, ongoing Rag-mediated recombination activity in Slp65-deficient pre-B-cell leukemias might well be a consequence of malignant transformation, resulting in correct IgL chain recombination, but not in aberrant V(D)J recombination events that would contribute to tumor progression. Spectral karyotyping analysis of Slp65-deficient pre-B-cell leukemias revealed chromosomal abnormalities, characterized by chromosomal gains, losses and gene amplifications that were heterogeneous in nature and did not appear to specifically affect the Ig or T cell receptor gene loci. 28 As we found duplications of the N-myc locus that were associated with N-myc amplification on the p53-deficient background, 28 it may be interesting to investigate whether these leukemias contain more regions with deletions or duplications involving tumor suppressors or oncogenes.
The proportions of mice developing leukemia in 3-83md Tg Btk/Slp65 double-deficient mice is low (B10%), when compared with Btk/Slp65 double-deficient mice that do not harbor an Ig transgene (B50-80%, dependent on mouse strain background). This is consistent with the previously reported observation that transgenic expression of a functional IgH chain prevents malignant transformation of c-Myc transgenic 29 or Slp65-deficient pre-B cells. 28 Such premature transgenic IgH chain expression considerably accelerates the passage of B-cell precursors through the pro-B-cell stage, thereby likely reducing the size of the cell population most susceptible to transformation. 29, 49 In particular, it was recently shown that an IgH chain induces Stat5 dephosphorylation downstream of IL-7R signaling. 50 As Slp65 is essential for pre-BCR-mediated downregulation of IL-7R-Jak3-Stat5 signaling 25, 50, 51 and Slp65-deficient pre-B-cell leukemias exhibit autocrine IL-7 production, it is attractive to speculate that transformation of Slp65-deficient pre-B cells is dependent on early oncogenic events that induce constitutive Jak3-Stat5 signaling at the pro-B-cell stage.
It may be argued that dilution of SLC-mediated proliferative signals by the 3-83md Tg conventional L chains contributes to the low leukemia incidence in 3-83md Tg Btk/Slp65 doubledeficient mice. This would be supported by the finding that conventional light chains inhibit the autonomous signaling capacity of the BCR. 52 However, the opposite is more likely, because the 3-83md is an autoreactive B-cell receptor that mimics autonomous pre-B-cell receptor signaling and induces proliferation of early B cells. 53 It is therefore well possible that Btk/Slp65 double-deficient mice transgenic for only the 3-83md IgH chain (which is not autoreactive) would not develop leukemia or at frequencies much lower than 10%. In this context, it is important to note that leukemia formation was completely lacking in Btk/Slp65 double-deficient mice that harbored a VH81X IgH transgene, (in contrast to the frequency of B10% in the presence of the autoreactive 3-83md IgH þ L chain transgene). Possibly, transformation of Slp65-deficient pre-B cells is restricted to IgH chains with specific structural properties. Particular IgH chain V regions may be associated with strong autonomous pre-BCR signaling, for example, because they enhance interaction with self-antigens 53 or with carbohydrates in the m IgH chain. 54 In such a model the 3-83md H chain but not the VH81X IgH chain would have these specific structural properties.
Because of the low leukemia frequencies in our mouse panels (B10% for all our genotypes, Table 2 ), we cannot formally rule out that Rag1 activity may to some extent contribute to the transformation process in a fraction of the leukemias. But, importantly, the finding that two Rag1/Btk/Slp65 triple-deficient mice developed leukemia in our 3-83md receptor editing model, demonstrates that Rag1 activity is not absolutely essential for malignant transformation of Btk/Slp65-deficient pre-B cells. Conversely, defective NHEJ, which is associated with oncogenic misjoining of Rag-induced breaks, 55, 56 did not appear to enhance lymphoma formation. Taken together, we therefore conclude that pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.
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